patent
Delhi HC Sets Standards for Pharmaceutical Patent Refusals
The Delhi High Court clarifies mandatory reasoning for patent refusals in Array Biopharma, curbing arbitrary use of Section 3(d) and 3(i) by the Indian Patent Office.
Browse the archive